BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8529516)

  • 21. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity.
    Ueda H; Ikegami H; Yamato E; Fu J; Fukuda M; Shen G; Kawaguchi Y; Takekawa K; Fujioka Y; Fujisawa T
    Diabetologia; 1995 May; 38(5):503-8. PubMed ID: 7489831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
    Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
    Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation.
    Bollheimer LC; Skelly RH; Chester MW; McGarry JD; Rhodes CJ
    J Clin Invest; 1998 Mar; 101(5):1094-101. PubMed ID: 9486980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
    Björklund A; Grill V
    Diabetes; 1999 Jul; 48(7):1409-14. PubMed ID: 10389846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
    Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
    Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased glucose sensitivity of stimulus-secretion coupling in islets from Psammomys obesus after diet induction of diabetes.
    Pertusa JA; Nesher R; Kaiser N; Cerasi E; Henquin JC; Jonas JC
    Diabetes; 2002 Aug; 51(8):2552-60. PubMed ID: 12145170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus.
    Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
    Diabet Med; 1994; 11(1):71-8. PubMed ID: 8181257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.
    Kaiser N; Nesher R; Oprescu A; Efendic S; Cerasi E
    Br J Pharmacol; 2005 Nov; 146(6):872-81. PubMed ID: 16158072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative hypersecretion of proinsulin in rat model of NIDDM.
    Leahy JL; Halban PA; Weir GC
    Diabetes; 1991 Aug; 40(8):985-9. PubMed ID: 1860563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect on insulin production sorting and secretion by major histocompatibility complex class II gene expression in the pancreatic beta-cell of transgenic mice.
    Grodsky GM; Ma YH; Cullen B; Sarvetnick N
    Endocrinology; 1992 Aug; 131(2):933-8. PubMed ID: 1639031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic changes in {beta}-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in psammomys obesus: impact of glycemic control.
    Kaiser N; Yuli M; Uçkaya G; Oprescu AI; Berthault MF; Kargar C; Donath MY; Cerasi E; Ktorza A
    Diabetes; 2005 Jan; 54(1):138-45. PubMed ID: 15616021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM
    Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-cell function across the spectrum of glucose tolerance in obese youth.
    Weiss R; Caprio S; Trombetta M; Taksali SE; Tamborlane WV; Bonadonna R
    Diabetes; 2005 Jun; 54(6):1735-43. PubMed ID: 15919795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin secretion and sensitivity in newly diagnosed NIDDM Caucasians in the UK.
    Owens DR; Luzio SD; Coates PA
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S19-24. PubMed ID: 8894476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects.
    Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG
    Metabolism; 1993 Jan; 42(1):30-5. PubMed ID: 8446045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.